- Conditions
- Osteoarthritis of Knee
- Interventions
- Triamcinolone Acetonide Low Dose, Triamcinolone Acetonide Standard Dose
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 55 Years to 85 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 248
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Severe Osteoarthritis of the Knee
- Interventions
- Ampion, Saline
- Biological · Drug
- Lead sponsor
- Ampio Pharmaceuticals. Inc.
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 1,043 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Englewood, Colorado
- Conditions
- Ankle Arthritis, Ankle Arthropathy
- Interventions
- Intra-articular injection, Peripheral nerve block
- Procedure
- Lead sponsor
- Slocum Research & Education Foundation
- Other
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2020
- U.S. locations
- 1
- States / cities
- Eugene, Oregon
- Conditions
- Osteoarthritis, Knee
- Interventions
- SI-613, Placebo
- Combination Product
- Lead sponsor
- Seikagaku Corporation
- Industry
- Eligibility
- 40 Years to 75 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 10
- States / cities
- Tucson, Arizona • Miami, Florida • Newton, Kansas + 6 more
- Conditions
- Osteoarthritis of the Knee
- Interventions
- FX006 32 mg, Placebo, FX006 16 mg
- Drug
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 310 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 39
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 36 more
- Conditions
- Primary Knee Osteoarthritis
- Interventions
- Allocetra, Placebo
- Drug · Other
- Lead sponsor
- Enlivex Therapeutics Ltd.
- Industry
- Eligibility
- 64 Years and older
- Enrollment
- 182 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 4
- States / cities
- Longwood, Florida • Miami, Florida • New Orleans, Louisiana + 1 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Liposomal bupivacaine, Standard of Care
- Drug
- Lead sponsor
- OhioHealth
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Knee Osteoarthritis
- Interventions
- HYMOVIS, Placebo
- Device
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 332 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Brimingham, Alabama • Phoenix, Arizona + 17 more
- Conditions
- Arthritis, Osteo Arthritis of the Knee
- Interventions
- Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, Intra articular injection
- Device · Drug
- Lead sponsor
- ZetrOZ, Inc.
- Industry
- Eligibility
- 65 Years to 85 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- Stamford, Connecticut • Dryden, New York
- Conditions
- Knee Osteoarthritis (Knee OA)
- Interventions
- genicular artery embolization, Corticosteroid Injection
- Device · Drug
- Lead sponsor
- North American Science Associates Ltd.
- Network
- Eligibility
- 40 Years and older
- Enrollment
- 126 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Neck Pain, Cervicalgia, Facet Joint Pain
- Interventions
- Intra-articular cervical zygapophyseal joint injection
- Procedure
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 3
- States / cities
- Palo Alto, California • Redwood City, California • Nashville, Tennessee
- Conditions
- Joint Pain
- Interventions
- Synvisc viscosupplementation
- Procedure
- Lead sponsor
- Sheltering Arms Physical Rehabilitation Hospitals
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Osteoarthritis
- Interventions
- Ketorolac Tromethamine Injection, Methylprednisolone Acetate Injection, Hylan G-F 20
- Drug
- Lead sponsor
- UConn Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Farmington, Connecticut
- Conditions
- Osteoarthritis, Knee
- Interventions
- Intracapsular Injection, Periarticular Injection
- Procedure
- Lead sponsor
- Broward Health
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Fort Lauderdale, Florida
- Conditions
- Knee Osteoarthritis
- Interventions
- Lorecivivint, Placebo
- Drug
- Lead sponsor
- Biosplice Therapeutics, Inc.
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 499 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 44
- States / cities
- Tucson, Arizona • Cerritos, California • La Mesa, California + 35 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- Triamcinolone acetonide-Ketorolac-Ropivacaine
- Drug
- Lead sponsor
- United Health Services Hospitals, Inc.
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Vestal, New York
- Conditions
- Osteoarthritis, Knee
- Interventions
- Bone Marrow Derived MSCs, Corticosteroid, Bone Marrow Aspirate
- Biological · Drug · Device
- Lead sponsor
- Next Generation Regenerative Medicine LLC
- Network
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 3
- States / cities
- Chesterfield, Missouri • Steubenville, Ohio • Salt Lake City, Utah
- Conditions
- Anterior Cruciate Ligament Injuries, Post-traumatic Osteoarthritis, PRP
- Interventions
- platelet rich plasma (PRP) injection, placebo saline injection
- Procedure
- Lead sponsor
- Hospital for Special Surgery, New York
- Other
- Eligibility
- 14 Years to 50 Years
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Total Knee Anthroplasty
- Interventions
- Intra-articular injection of bupivacaine in the knee joint, intra-articular injection of Exparel in the knee joint, Zynrelef
- Drug
- Lead sponsor
- Foundation for Orthopaedic Research and Education
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Arthritis
- Interventions
- Micro-Fragmented Adipose Tissue (MFAT), Triamcinolone Acetonide 10mg/mL
- Biological · Drug
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Osteoarthritis, Knee, Knee Osteoarthritis, Patellofemoral Osteoarthritis
- Interventions
- HYMOVIS plus Physical Exercise Program (PEP), Physical Exercise Program (PEP) alone
- Device · Other
- Lead sponsor
- Fidia Pharma USA Inc.
- Industry
- Eligibility
- 21 Years to 60 Years
- Enrollment
- 148 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 10
- States / cities
- Tucson, Arizona • Encinitas, California • Los Angeles, California + 5 more
- Conditions
- OSTEOARTHRITIS
- Interventions
- Agilus, Normal saline
- Device
- Lead sponsor
- Cartiva, Inc.
- Industry
- Eligibility
- 18 Years to 95 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 19
- States / cities
- Farmington, Connecticut • Royal Palm Beach, Florida • Chicago, Illinois + 14 more
- Conditions
- Knee Osteoarthritis, Osteo Arthritis Knee
- Interventions
- Microfragmented Adipose Tissue derived using the Lipogems® System, Saline Injection
- Device · Drug
- Lead sponsor
- Lipogems International spa
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 173 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 16
- States / cities
- Phoenix, Arizona • Encinitas, California • La Mesa, California + 13 more
- Conditions
- Osteoarthritis of the Shoulder, Osteoarthritis of the Hip
- Interventions
- FX006 32 mg, TAcs 40 mg
- Drug
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 6
- States / cities
- El Cajon, California • La Mesa, California • San Diego, California + 3 more